The Unseen Link: How Viral Infections Could Rewire the Immune System and Complicate Anesthesia
A new study published in the Annals of Clinical and Translational Neurology reveals a potential shared mechanism behind immune dysregulation in multiple sclerosis (MS) and following COVID-19. Researchers found that in both conditions, hematopoietic stem and progenitor cells (HSPCs) in the bone marrow undergo epigenetic reprogramming. This is characterized by the downregulation of the histone variant H3.3 and the consequent overexpression of endogenous retroelements (EREs). This “H3.3low/EREhigh” signature drives skewed myelopoiesis—an enhanced production of innate immune cells—which is a known driver of MS progression. The findings suggest that infections like SARS-CoV-2 can trigger a lasting innate immune reprogramming that mirrors the chronic inflammatory state seen in neurological diseases.
Why it might matter to you: For an anesthesiologist, a patient’s underlying immune and inflammatory status is a critical determinant of perioperative risk and hemodynamic stability. This research implies that a recent viral infection could induce a prolonged state of innate immune activation, potentially altering a patient’s response to anesthetic agents and increasing susceptibility to complications like exaggerated inflammatory responses or hemodynamic instability. Understanding this epigenetic link could refine preoperative assessment, prompting closer evaluation of patients with recent infections and influencing decisions on anesthetic technique and perioperative monitoring to mitigate unforeseen systemic inflammation.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
